This Little-Known Healthcare Stock Is Up 90% This Year, and the Party Might Just Be Getting Started

Oscar Health is up 90% this year and is guiding to as much as $19 billion in revenue and $450 million in operating earnings for 2026, while the article argues the stock still looks undervalued at an $8.6 billion market cap. The company has 3.2 million customers and could potentially double that base to 6.5 million over five years, which the piece says could support about $2.5 billion in annual operating income at a 5% margin. The article is broadly bullish on Oscar's long-term growth and profitability outlook, though it notes near-term losses in the next three quarters.

Analysis

OSCR’s rerating is less about this quarter’s print than about the market finally assigning value to a scaled ACA distribution franchise with improving unit economics. The second-order effect is that every additional member should carry higher incremental margin than the last, but only if medical-cost trends stay inside the corridor; in managed care, the path to durable earnings is usually interrupted by one or two bad utilization cycles before the market accepts the new steady-state.

The crowding risk is that investors are extrapolating a clean glide path from a single strong year into a multi-year compounding story. That’s dangerous because ACA exposure is politically and actuarially noisy: a favorable membership mix today can become a reserve or pricing issue 6-18 months later if utilization, risk-adjustment, or reimbursement assumptions drift. The market is paying up for “platform” characteristics, but the business still has insurer-like tail risk, not software-like visibility.

The real beneficiaries beyond OSCR are digital-health vendors, telehealth enablement, and brokers that can plug into a member-acquisition engine with better conversion and lower service costs; the losers are legacy ACA carriers with weaker service and less elastic cost structures. If Oscar continues to take share, the more interesting short is not another pure-play insurer at the same scale, but firms whose economics depend on friction in the enrollment and servicing process—those rents get compressed as consumer experience becomes a battleground.

Near term, the stock is most vulnerable to any sign that the current earnings cadence is being pulled forward by one-off favorable utilization or mix effects, because the multiple already discounts several years of execution. Over 3-12 months, the biggest reversal trigger is a guidance reset tied to medical-loss pressure or regulatory changes in ACA economics; over 2-3 years, the main upside risk is that the market underestimates how much operating leverage a national, digitally native payer can generate once membership crosses the next scale threshold.

Key Decisions for Investors

• Trade OSCR with a barbell: long the common into pullbacks only if implied medical-cost risk stays contained, but cap exposure with short-dated call overwrites into strength; the stock has already re-rated and is more vulnerable to disappointment than upside surprise over the next 1-2 quarters.
• Pair trade: long OSCR / short a higher-cost legacy managed-care name with similar ACA exposure for 6-12 months; the thesis is that service-led share gains will continue to compress operating leverage gaps, while the short leg is exposed to slower response and worse customer retention.
• If you want convexity, buy 6-12 month OSCR call spreads rather than outright equity; this isolates the rerating tail while limiting damage if underwriting assumptions mean-revert before the market can fully capitalize the growth story.
• Watch for an earnings entry point after any utilization-driven selloff: if the stock pulls back 15%+ on normal volatility without a share-loss narrative, that is the best risk/reward window to add, because the long-term share gain thesis remains intact.
• Avoid chasing OSCR after strong guidance beats unless there is evidence of sustained lower medical loss ratio; the downside from a single actuarial reset can overwhelm the incremental upside from another quarter of membership growth.